Anthony Gonçalves

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.

François Bertucci, Mario Campone, F. Bertucci, 2017, European journal of cancer.

Surgical resection of brain metastases from breast cancer in the modern era: clinical outcome and prognostic factors.

Emeline Tabouret, Philippe Metellus, D. Figarella-Branger, 2013, Anticancer research.

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis

Daniel Birnbaum, Jean-Paul Borg, Pascal Finetti, 2011, Breast Cancer Research and Treatment.

Efficacy of vemurafenib in patients (pts) with non-small cell lung cancer (NSCLC) with BRAFV600 mutation.

David M. Hyman, Vivek Subbiah, Jean-Yves Blay, 2017 .

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.

Nicolas Servant, Anne Vincent-Salomon, Xavier Paoletti, 2015, The Lancet. Oncology.

Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on “Cancer outside the Hospital Walls”

Dominique Maraninchi, François Bertucci, F. Bertucci, 2019, Cancers.

The ErbB2 Signaling Network as a Target for Breast Cancer Therapy

A. Gonçalves, Anthony Gonçalves, Ali Badache, 2006, Journal of Mammary Gland Biology and Neoplasia.